| Common Name |
Serinyl-Asparagine
| Description |
Serinyl-Asparagine is a dipeptide composed of serine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
| Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Structure for HMDB29034 (Serinyl-Asparagine)
| Synonyms |
| Value |
Source |
L-Serinyl-L-asparagineHMDB
S-N DipeptideHMDB
Ser-asnHMDB
Serine asparagine dipeptideHMDB
Serine-asparagine dipeptideHMDB
SerinylasparagineHMDB
sn DipeptideHMDB
| Chemical Formlia |
C7H13N3O5
| Average Molecliar Weight |
219.1952
| Monoisotopic Molecliar Weight |
219.085520541
| IUPAC Name |
2-(2-amino-3-hydroxypropanamido)-3-carbamoylpropanoic acid
| Traditional Name |
2-(2-amino-3-hydroxypropanamido)-3-carbamoylpropanoic acid
| CAS Registry Number |
Not Available
| SMILES |
NC(CO)C(=O)NC(CC(N)=O)C(O)=O
| InChI Identifier |
InChI=1S/C7H13N3O5/c8-3(2-11)6(13)10-4(7(14)15)1-5(9)12/h3-4,11H,1-2,8H2,(H2,9,12)(H,10,13)(H,14,15)
| InChI Key |
LTFSLKWFMWZEBD-UHFFFAOYSA-N
| Chemical Taxonomy |
| Description |
This compound belongs to the class of chemical entities known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
| Kingdom |
Chemical entities
| Super Class |
Organic compounds
| Class |
Organic acids and derivatives
| Sub Class |
Carboxylic acids and derivatives
| Direct Parent |
Dipeptides
| Alternative Parents |
Asparagine and derivatives
N-acyl-alpha amino acids
Serine and derivatives
Alpha amino acid amides
Fatty acids and conjugates
Fatty amides
Secondary carboxylic acid amides
Primary carboxylic acid amides
Amino acids
Monocarboxylic acids and derivatives
Carboxylic acids
Hydrocarbon derivatives
Monoalkylamines
Carbonyl compounds
Organic oxides
Organopnictogen compounds
Primary alcohols
| Substituents |
Alpha-dipeptide
Asparagine or derivatives
N-acyl-alpha amino acid or derivatives
N-acyl-alpha-amino acid
Alpha-amino acid amide
Serine or derivatives
Alpha-amino acid or derivatives
Fatty amide
Fatty acid
Fatty acyl
Amino acid or derivatives
Carboxamide group
Secondary carboxylic acid amide
Primary carboxylic acid amide
Amino acid
Monocarboxylic acid or derivatives
Carboxylic acid
Alcohol
Organonitrogen compound
Organooxygen compound
Primary alcohol
Primary aliphatic amine
Primary amine
Hydrocarbon derivative
Organic oxide
Carbonyl group
Organopnictogen compound
Amine
Organic oxygen compound
Organic nitrogen compound
Aliphatic acyclic compound
| Molecliar Framework |
Aliphatic acyclic compounds
| External Descriptors |
Not Available
| Ontology |
| Status |
Expected but not Quantified
| Origin |
Endogenous
| Biofunction |
Not Available
| Application |
Not Available
| Cellliar locations |
Not Available
| Physical Properties |
| State |
Solid
| Experimental Properties |
| Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-5.88Extrapolated
| Predicted Properties |
| Property |
Value |
Source |
Water Solubility21.3 mg/mLALOGPS
logP-3.5ALOGPS
logP-5.9ChemAxon
logS-1ALOGPS
pKa (Strongest Acidic)3.33ChemAxon
pKa (Strongest Basic)7.85ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area155.74 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity47.2 m3·mol-1ChemAxon
Polarizability19.95 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
| Spectra |
| Spectra |
Not Available
| Biological Properties |
| Cellliar Locations |
Not Available
| Biofluid Locations |
Not Available
| Tissue Location |
Not Available
| Pathways |
Not Available
| Normal Concentrations |
| Not Available |
| Abnormal Concentrations |
|
Not Available
| Associated Disorders and Diseases |
| Disease References |
None
| Associated OMIM IDs |
None
| External Links |
| DrugBank ID |
Not Available
| DrugBank Metabolite ID |
Not Available
| Phenol Explorer Compound ID |
Not Available
| Phenol Explorer Metabolite ID |
Not Available
| FoodDB ID |
Not Available
| KNApSAcK ID |
Not Available
| Chemspider ID |
Not Available
| KEGG Compound ID |
Not Available
| BioCyc ID |
Not Available
| BiGG ID |
Not Available
| Wikipedia Link |
Not Available
| NuGOwiki Link |
HMDB29034
| Metagene Link |
HMDB29034
| METLIN ID |
Not Available
| PubChem Compound |
Not Available
| PDB ID |
Not Available
| ChEBI ID |
Not Available
Product: Lusutrombopag
References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Not Available |
| General References |
- Broberg K, Hoglund M, Gustafsson C, Bjork J, Ingvar C, Albin M, Olsson H: Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanoma. Cancer Lett. 2007 Dec 8;258(1):38-44. Epub 2007 Sep 27. [PubMed:17900800 ]
|
PMID: 24121738
